​

Daré Bioscience (DARE) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DARE Stock Forecast

Daré Bioscience (DARE) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $12.00, with a high of $12.00 and a low of $12.00. This represents a 284.62% increase from the last price of $3.12.

- $3 $6 $9 $12 $15 High: $12 Avg: $12 Low: $12 Last Closed Price: $3.12

DARE Stock Rating

Daré Bioscience stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (83.33%), 1 Hold (16.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 1 5 0 Strong Sell Sell Hold Buy Strong Buy

DARE Price Target Upside V Benchmarks

TypeNameUpside
StockDaré Bioscience284.62%
SectorHealthcare Stocks 24.81%
IndustryBiotech Stocks 65.78%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$12.00
Last Closing Price$3.12$3.12$3.12
Upside/Downside--284.62%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25121--4
May, 25121--4
Apr, 25121--4
Mar, 25121--4
Feb, 25121--4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 24, 2024Douglas TsaoH.C. Wainwright$12.00$3.50242.86%284.62%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 24, 2024H.C. WainwrightBuyBuyhold
Aug 13, 2024H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

$-500 $-390 $-280 $-170 $-60 $50 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-10.93$-7.52$-4.39$-4.15$-477.04----
Avg Forecast$-9.82$-7.03$-3.80$-4.46$-0.35$-1.52$-1.34$0.41$7.63
High Forecast$-6.98$-5.00$-3.80$-3.81$-0.24$-1.14$-0.20$0.61$7.63
Low Forecast$-13.68$-9.80$-3.80$-5.23$-0.46$-1.90$-2.47$0.21$7.63
Surprise %11.30%6.97%15.53%-6.95%136197.14%----

Revenue Forecast

$0 $60M $120M $180M $240M $300M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported--$10.00M$2.81M$9.78M----
Avg Forecast$645.00K$1.67M$10.00M$3.38M$1.08M$3.27M$42.10M$70.18M$272.61M
High Forecast$840.22K$2.17M$10.00M$3.55M$2.12M$3.27M$42.10M$70.18M$272.61M
Low Forecast$501.39K$1.30M$10.00M$3.20M$36.52K$3.27M$42.10M$70.18M$272.61M
Surprise %----16.83%806.05%----

Net Income Forecast

$-5B $-4B $-3B $-2B $-500M $500M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-27.40M$-38.33M$-30.95M$-30.16M$-4.05B----
Avg Forecast$-71.44M$-51.16M$-27.65M$-30.16M$-2.55M$-11.06M$-9.71M$2.98M$55.47M
High Forecast$-50.76M$-36.35M$-27.65M$-27.72M$-1.77M$-8.26M$-1.42M$4.44M$55.47M
Low Forecast$-99.55M$-71.29M$-27.65M$-38.02M$-3.33M$-13.85M$-18.01M$1.53M$55.47M
Surprise %-61.65%-25.09%11.94%-159092.09%----

DARE Forecast FAQ

Is Daré Bioscience stock a buy?

Daré Bioscience stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Daré Bioscience is a favorable investment for most analysts.

What is Daré Bioscience's price target?

Daré Bioscience's price target, set by 6 Wall Street analysts, averages $12 over the next 12 months. The price target range spans from $12 at the low end to $12 at the high end, suggesting a potential 284.62% change from the previous closing price of $3.12.

How does Daré Bioscience stock forecast compare to its benchmarks?

Daré Bioscience's stock forecast shows a 284.62% upside, outperforming the average forecast for the healthcare stocks sector (24.81%) and outperforming the biotech stocks industry (65.78%).

What is the breakdown of analyst ratings for Daré Bioscience over the past three months?

  • June 2025: 25.00% Strong Buy, 50.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 25.00% Strong Buy, 50.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 25.00% Strong Buy, 50.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.

What is Daré Bioscience’s EPS forecast?

Daré Bioscience's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.52, marking a -99.68% decrease from the reported $-477 in 2024. Estimates for the following years are $-1.34 in 2026, $0.41 in 2027, and $7.63 in 2028.

What is Daré Bioscience’s revenue forecast?

Daré Bioscience's average annual revenue forecast for its fiscal year ending in December 2025 is $3.27M, reflecting a -66.61% decrease from the reported $9.78M in 2024. The forecast for 2026 is $42.1M, followed by $70.18M for 2027, and $272.61M for 2028.

What is Daré Bioscience’s net income forecast?

Daré Bioscience's net income forecast for the fiscal year ending in December 2025 stands at $-11.058M, representing a -99.73% decrease from the reported $-4.054B in 2024. Projections indicate $-9.713M in 2026, $2.98M in 2027, and $55.47M in 2028.